Preventive Effect Of Morin On Cardiac Marker Enzymes, Lipid Peroxides And Antioxidants In Isoproterenol-induced Cardiotoxicity In Wistar Rats | 16660
Journal of Clinical & Experimental Cardiology
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
It is now over 100 years since the discovery of the cardiac conduction system, consisting of three main parts, the sinus node, the
atrio-ventricular node and the His?Purkinje system. The system is vital for the initiation and co-ordination of the heartbeat.
Over the last decade, immense strides have been made in our understanding of the cardiac conduction system. It has been
shown that the system has a unique embryological origin, distinct from that of the working myocardium, and is more extensive
than originally thought with additional structures: atrio-ventricular rings, a third node (retro-aortic node) and pulmonary and
aortic sleeves. It has been shown that the expression of ion channels, intracellular calcium-handling proteins and gap junction
channels in the system is specialized (different from that in the ordinary working myocardium), but appropriate to explain the
functioning of the system, although there is continued debate concerning the ionic basis of pacemaking. We are beginning to
understand the mechanisms (fibrosis and remodeling of ion channels and related proteins) responsible for dysfunction of the
system (bradycardia, heart block and bundle branch block) associated with atrial fibrillation and heart failure and even athletic
training. Equally, we are beginning to appreciate how naturally occurring mutations in ion channels cause congenital cardiac
conduction system dysfunction. Finally, current therapies, the status of a new therapeutic strategy (use of a specific heart rate
lowering drug) and a potential new therapeutic strategy (bio-pacemaking) are of great interests globally.
Halina Dobrzynski has completed his Ph.D. in 2000 from University of Leeds, UK and Postdoctoral studies from Universities of Leeds and Manchester, UK. She
is an Associate Professor/Senior Lecturer at the Institute of Cardiovascular Sciences, University of Manchester, UK. On PubMed she has around 70 publications
in reputed journals. Her expertise in the anatomy, immunohistochemistry and histology of the cardiac conduction system has been sought by many scientists
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals